Clinical Trial Update: A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing safety and effectiveness of acetaminophen 4000 mg/day plus naproxen 750 mg/day for hip or knee osteoarthritis; the study status is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• Acetaminophen (Acetaminophen)
• Naproxen (Naproxen)

Snippet

Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide | Conditions: Osteoarthritis, Hip, Osteoarthritis, Knee | Phase 3 | Status: COMPLETED